vs

Side-by-side financial comparison of Origin Bancorp, Inc. (OBK) and U S PHYSICAL THERAPY INC (USPH). Click either name above to swap in a different company.

U S PHYSICAL THERAPY INC is the larger business by last-quarter revenue ($202.7M vs $104.0M, roughly 1.9× Origin Bancorp, Inc.). Origin Bancorp, Inc. runs the higher net margin — 26.6% vs 2.0%, a 24.6% gap on every dollar of revenue. Over the past eight quarters, U S PHYSICAL THERAPY INC's revenue compounded faster (14.1% CAGR vs 3.9%).

Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

OBK vs USPH — Head-to-Head

Bigger by revenue
USPH
USPH
1.9× larger
USPH
$202.7M
$104.0M
OBK
Higher net margin
OBK
OBK
24.6% more per $
OBK
26.6%
2.0%
USPH
Faster 2-yr revenue CAGR
USPH
USPH
Annualised
USPH
14.1%
3.9%
OBK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
OBK
OBK
USPH
USPH
Revenue
$104.0M
$202.7M
Net Profit
$27.7M
$4.2M
Gross Margin
19.8%
Operating Margin
8.3%
Net Margin
26.6%
2.0%
Revenue YoY
12.3%
Net Profit YoY
-55.1%
EPS (diluted)
$0.89
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OBK
OBK
USPH
USPH
Q1 26
$104.0M
Q4 25
$103.4M
$202.7M
Q3 25
$109.8M
$197.1M
Q2 25
$83.5M
$197.3M
Q1 25
$94.1M
$183.8M
Q4 24
$78.3M
$180.4M
Q3 24
$90.8M
$168.0M
Q2 24
$96.4M
$167.2M
Net Profit
OBK
OBK
USPH
USPH
Q1 26
$27.7M
Q4 25
$29.5M
$4.2M
Q3 25
$8.6M
$13.1M
Q2 25
$14.6M
$12.4M
Q1 25
$22.4M
$9.9M
Q4 24
$14.3M
$9.2M
Q3 24
$18.6M
$6.6M
Q2 24
$21.0M
$7.5M
Gross Margin
OBK
OBK
USPH
USPH
Q1 26
Q4 25
19.8%
Q3 25
18.7%
Q2 25
21.1%
Q1 25
16.9%
Q4 24
18.0%
Q3 24
17.3%
Q2 24
20.3%
Operating Margin
OBK
OBK
USPH
USPH
Q1 26
Q4 25
36.2%
8.3%
Q3 25
10.0%
12.8%
Q2 25
22.3%
12.6%
Q1 25
30.4%
10.7%
Q4 24
23.0%
10.9%
Q3 24
26.1%
7.6%
Q2 24
27.7%
9.3%
Net Margin
OBK
OBK
USPH
USPH
Q1 26
26.6%
Q4 25
28.5%
2.0%
Q3 25
7.9%
6.7%
Q2 25
17.5%
6.3%
Q1 25
23.8%
5.4%
Q4 24
18.2%
5.1%
Q3 24
20.5%
3.9%
Q2 24
21.8%
4.5%
EPS (diluted)
OBK
OBK
USPH
USPH
Q1 26
$0.89
Q4 25
$0.95
$-0.44
Q3 25
$0.27
$0.48
Q2 25
$0.47
$0.58
Q1 25
$0.71
$0.80
Q4 24
$0.45
$0.52
Q3 24
$0.60
$0.39
Q2 24
$0.67
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OBK
OBK
USPH
USPH
Cash + ST InvestmentsLiquidity on hand
$35.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$476.4M
Total Assets
$10.2B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OBK
OBK
USPH
USPH
Q1 26
Q4 25
$424.2M
$35.6M
Q3 25
$626.9M
$31.1M
Q2 25
$334.1M
$34.1M
Q1 25
$486.2M
$39.2M
Q4 24
$470.2M
$41.4M
Q3 24
$321.2M
$117.0M
Q2 24
$288.1M
$112.9M
Stockholders' Equity
OBK
OBK
USPH
USPH
Q1 26
$1.3B
Q4 25
$1.2B
$476.4M
Q3 25
$1.2B
$503.6M
Q2 25
$1.2B
$500.8M
Q1 25
$1.2B
$497.3M
Q4 24
$1.1B
$488.9M
Q3 24
$1.1B
$482.8M
Q2 24
$1.1B
$484.6M
Total Assets
OBK
OBK
USPH
USPH
Q1 26
$10.2B
Q4 25
$9.7B
$1.2B
Q3 25
$9.8B
$1.2B
Q2 25
$9.7B
$1.2B
Q1 25
$9.8B
$1.2B
Q4 24
$9.7B
$1.2B
Q3 24
$10.0B
$1.0B
Q2 24
$9.9B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OBK
OBK
USPH
USPH
Operating Cash FlowLast quarter
$24.9M
Free Cash FlowOCF − Capex
$21.0M
FCF MarginFCF / Revenue
10.4%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
6.00×
TTM Free Cash FlowTrailing 4 quarters
$61.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OBK
OBK
USPH
USPH
Q1 26
Q4 25
$158.9M
$24.9M
Q3 25
$59.3M
$19.9M
Q2 25
$20.6M
$34.9M
Q1 25
$35.6M
$-4.7M
Q4 24
$108.5M
$19.4M
Q3 24
$39.6M
$22.1M
Q2 24
$11.9M
$29.0M
Free Cash Flow
OBK
OBK
USPH
USPH
Q1 26
Q4 25
$151.1M
$21.0M
Q3 25
$56.8M
$15.6M
Q2 25
$19.6M
$31.6M
Q1 25
$34.8M
$-7.3M
Q4 24
$86.4M
$16.9M
Q3 24
$32.2M
$19.6M
Q2 24
$6.5M
$26.7M
FCF Margin
OBK
OBK
USPH
USPH
Q1 26
Q4 25
146.0%
10.4%
Q3 25
51.7%
7.9%
Q2 25
23.5%
16.0%
Q1 25
37.0%
-3.9%
Q4 24
110.3%
9.4%
Q3 24
35.5%
11.7%
Q2 24
6.8%
15.9%
Capex Intensity
OBK
OBK
USPH
USPH
Q1 26
Q4 25
7.6%
1.9%
Q3 25
2.3%
2.2%
Q2 25
1.2%
1.6%
Q1 25
0.8%
1.4%
Q4 24
28.1%
1.4%
Q3 24
8.1%
1.5%
Q2 24
5.6%
1.4%
Cash Conversion
OBK
OBK
USPH
USPH
Q1 26
Q4 25
5.38×
6.00×
Q3 25
6.88×
1.52×
Q2 25
1.41×
2.81×
Q1 25
1.59×
-0.47×
Q4 24
7.60×
2.10×
Q3 24
2.13×
3.34×
Q2 24
0.57×
3.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OBK
OBK

Net Interest Income$87.2M84%
Noninterest Income$16.8M16%

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

Related Comparisons